CHALLENGES OF TREATING GLAUCOMA DURING PREGNANCY

• DOI: https://doi.org/10.22533/at.ed.159512503018

• Palavras-chave: Glaucoma; Gestation; Therapeutic indication

• Keywords: Glaucoma; Gestation; Therapeutic indication

• Abstract:

  Glaucoma, the leading cause of irreversible blindness, represents a challenge in management during pregnancy due to the risks of medication to the fetus. This study reviews recent literature on the subject. During the first trimester, medication is avoided, but Brimonidine is used if necessary. In the second trimester, in addition to Brimonidine, beta-blockers, prostaglandin analogues and carbonic anhydrase inhibitors can be used, despite their possible adverse effects on the fetus. In late pregnancy and during lactation, Brimonidine is contraindicated, with beta-blockers and CAIs being options. Laser therapies are safe in any period, but access is limited in Brazil. Filter surgeries are the last option from the second trimester onwards. Treatment monitoring is crucial to ensure efficacy and safety, highlighting the importance of access to laser as a safe therapeutic alternative for pregnant women.